Your browser doesn't support javascript.
loading
A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya.
Wasunna, Monique K; Rashid, Juma R; Mbui, Jane; Kirigi, George; Kinoti, Dedan; Lodenyo, Hudson; Felton, J Mark; Sabin, Antony J; Albert, M John; Horton, John.
Affiliation
  • Wasunna MK; Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Am J Trop Med Hyg ; 73(5): 871-6, 2005 Nov.
Article in En | MEDLINE | ID: mdl-16282296
Subject(s)
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leishmania donovani / Aminoquinolines / Leishmaniasis, Visceral / Antiprotozoal Agents Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Animals / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Am J Trop Med Hyg Year: 2005 Type: Article Affiliation country: Kenya
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leishmania donovani / Aminoquinolines / Leishmaniasis, Visceral / Antiprotozoal Agents Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Animals / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Am J Trop Med Hyg Year: 2005 Type: Article Affiliation country: Kenya